Feature

AML Complexity Uncovered: A Unified Whole Genome and Informatics Approach for High Resolution Disease Understanding

Standard-of-care (SOC) genomic testing in acute myeloid leukemia (AML) has historically resulted in fragmented, incomplete genomic profiles that mask clinically significant biology.

  • March 12, 2026

Share

  • 1

    Shift towards whole genome sequencing in hematology.

  • 2

    Significance of MEASURE–ATLAS study findings.

  • 3

    Identification of pathogenic variants missed by SOC testing.

  • 4

    WGS reveals inherited predispositions and structural variants.

  • 5

    Technical requirements for WGS-based research workflows.

  • 6

    Illumina's ecosystem enhances genomic profiling capabilities.

Original Source(s)

AML Complexity Uncovered: A Unified Whole Genome and Informatics Approach for High Resolution Disease Understanding

  • March 12, 2026

Related Content

Enhancing Immune Thrombocytopenia Education and Support: Insights From a Learning Exchange Program

GIMEMA ALL2820: Chemotherapy-Free Regimen Studied in Front-Line Setting

As front-line therapy, a chemotherapy-free regimen combining the tyrosine kinase inhibitor (TKI) ponatinib and the bispecific T-cell engager blinatumomab significantly outperformed standard treatment ...

A Comprehensive Review of Monoclonal Gammopathy of Undetermined Significance